2020
AACR offers monthly "Editors' Picks" from our journals. We highlight one article from each issue that has been determined a "must read" by the Editors. Be sure to bookmark this page, as it will be updated on a monthly basis.
Sign up for an email alert for new monthly picks.
:: 2021 Picks :: 2020 Picks
January
Blood Cancer Discovery
Sphingosine-1-Phosphate Receptor 3 Potentiates Inflammatory Programs in Normal and Leukemia Stem Cells to Promote Differentiation
Blood Cancer Discov January 2021
Cancer Discovery
Inhibition of Nuclear Pore Complex Formation Selectively Induces Cancer Cell Death
Cancer Discov January 2021
Cancer Epidemiology, Biomarkers & Prevention
Assessing Impact of HPV Vaccination on Cervical Cancer Incidence among Women Aged 15–29 Years in the United States, 1999–2017: An Ecologic Study
Cancer Epidemiol Bio Prev January 2021
Cancer Immunology Research
The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment
Cancer Immunol Res January 2021
Cancer Prevention Research
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians
Cancer Prev Res January 2021
Cancer Research
The Amino-Terminal Oligomerization Domain of Angiopoietin-2 Affects Vascular Remodeling, Mammary Gland Tumor Growth, and Lung Metastasis in Mice
Cancer Res January 2021
Functional Precision Medicine Identifies New Therapeutic Candidates for Medulloblastoma
Cancer Res January 2021
Clinical Cancer Research
Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial
Clin Cancer Res January 2021
A Phase Ib Study of Alpelisib or Buparlisib Combined with Tamoxifen Plus Goserelin in Premenopausal Women with HR-Positive HER2-Negative Advanced Breast Cancer
Clin Cancer Res January 2021
Molecular Cancer Research
Progesterone Receptor Is a Haploinsufficient Tumor-Suppressor Gene in Cervical Cancer
Mol Cancer Res January 2021
Molecular Cancer Therapeutics
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis–Addicted Breast Tumor Growth
Mol Cancer Ther January 2021
American Association for Cancer Research
615 Chestnut Street | 17th Floor | Philadelphia, PA 19106-4404
Phone: (215) 440-9300 | Fax: (215) 440-9354 | E-mail: pubs@aacr.org